Company news
Modalis Therapeutics Corporation news in 2026
Modalis Therapeutics Corporation's news releases, calls and decks from 2026, newest first.
Notice Regarding the Recording of Non-Operating Income (Foreign Exchange Income)
November 12, 2026
Notice Regarding Designation of Exercise Suspension Period for the 19th Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions)
November 12, 2026
Financial Results for the Nine Months Ended September 30, 2026
November 12, 2026
Consolidated Financial Results for the Nine Months Ended September 30, 2026 [Japanese GAAP]
November 12, 2026
Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy
September 10, 2026
(Correction) Regarding Corrections to the "Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]"
August 13, 2026
Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]
August 10, 2026
Business Plans and Matters Related to Growth Potential
July 14, 2026
Decks in 2026
- Q3 2026 Earnings Presentation
Earnings · 53 slides · Nov 12, 2026
- Q2 2026 Earnings Presentation
Earnings · 5 slides · Aug 14, 2026
- Q2 2026 Earnings Presentation
Earnings · 50 slides · Aug 10, 2026
- Q2 2026 Earnings Presentation
Earnings · 51 slides · Aug 10, 2026
- Q1 2026 Earnings Presentation
Earnings · 48 slides · May 13, 2026